8 Result(s)

Article

Tislelizumab plus zanubrutinib for Richter transformation: the phase 2 RT1 trial

In patients with chronic lymphocytic leukemia, Richter transformation (RT) reflects the development of an aggressive lymphoma that is associated with poor response to chemotherapy and short survival. We initia...

Othman Al-Sawaf, Rudy Ligtvoet, Sandra Robrecht, Janina Stumpf… in Nature Medicine (2024)

Article

Treatment with idelalisib in patients with chronic lymphocytic leukemia – real world data from the registry of the German CLL Study Group

Idelalisib in combination with rituximab is an efficacious treatment for patients suffering from chronic lymphocytic leukemia (CLL) with known limitations due to toxicities. However, the benefit after prior B...

Julia von Tresckow, Nikola Heyl, Sandra Robrecht, Adam Giza… in Annals of Hematology (2023)

Article

MRI-based long-term follow-up of indolent orbital lymphomas after curative radiotherapy: imaging remission criteria and volumetric regression kinetics

We systematically analyzed the kinetics of tumor regression, the impact of residual lesions on disease control and the applicability of the Lugano classification in follow-up MRI of orbital non-Hodgkin lymphom...

Christian Hoffmann, Christopher Mohr, Patricia Johansson… in Scientific Reports (2023)

Article

Sequential treatment with bendamustine, obinutuzumab (GA101) and Ibrutinib in chronic lymphocytic leukemia (CLL): final results of the CLL2-BIG trial

Julia von Tresckow, Paula Cramer, Sandra Robrecht, Petra Langerbeins… in Leukemia (2022)

Article

Cannabinoids drive Th17 cell differentiation in patients with rheumatic autoimmune diseases

Konstantin Kotschenreuther, Iris Waqué, Shuaifeng Yan… in Cellular & Molecular Immunology (2021)

Article

COVID-19 among fit patients with CLL treated with venetoclax-based combinations

Moritz Fürstenau, Petra Langerbeins, Nisha De Silva, Anna Maria Fink… in Leukemia (2020)